GVBL Q1 FY27 results at a glance
GENOMIC VALLEY BIOTECH LIMITED Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹0.04 cr |
|---|
| Revenue YoY | -57.8% |
|---|
| Operating profit | ₹0.01 cr |
|---|
| Operating margin | 38.5% |
|---|
| Net profit | ₹0.01 cr |
|---|
| Net profit YoY | -40.7% |
|---|
| Net profit QoQ | +278.8% |
|---|
| Net margin | 38.5% |
|---|
| Basic EPS | ₹0.05 |
|---|
| TTM revenue | ₹0.22 cr |
|---|
| TTM net profit | ₹0.04 cr |
|---|
| TTM net margin | 19.3% |
|---|
GVBL Q1 FY27 results: what the numbers say
GENOMIC VALLEY BIOTECH LIMITED (GVBL) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹0.04 cr and a net profit of ₹0.01 cr, translating into earnings per share of ₹0.05.
Compared with the same quarter a year earlier, revenue declined sharply by -57.8% and net profit declined strongly by -40.7%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹0.01 cr, an operating margin of 38.5% versus 27.4% a year ago — a gain of 11.1 percentage points.
GVBL quarter-wise results table
Revenue
₹0.04 cr
-57.8% YoY
Net profit
₹0.01 cr
-40.7% YoY
Operating profit
₹0.01 cr
-40.7% YoY
GENOMIC VALLEY BIOTECH LIMITED (GVBL) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹0.04 cr | ₹0.01 cr | ₹0.01 cr | 38.5% | 38.5% | ₹0.05 | -40.7% | +278.8% |
| Q4 FY262026-03-31 | ₹0.04 cr | ₹0 cr | -₹0.01 cr | 4.2% | -21.8% | ₹-0.03 | +90.2% | -177.7% |
| Q3 FY262025-12-31 | ₹0.05 cr | ₹0.01 cr | ₹0.01 cr | 21.0% | 21.0% | ₹0.03 | — | -57.3% |
| Q1 FY262025-06-30 | ₹0.09 cr | ₹0.02 cr | ₹0.02 cr | 27.4% | 27.4% | ₹0.08 | — | +129.5% |
| Q4 FY252025-03-31 | ₹0.26 cr | ₹0 cr | -₹0.08 cr | 0.7% | -31.7% | ₹-0.27 | — | — |
| TTM (last 4 quarters) | ₹0.22 cr | ₹0.05 cr | ₹0.04 cr | 23.8% | 19.3% | ₹0.13 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
GVBL quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
GENOMIC VALLEY BIOTECH LIMITED quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q1 FY262025-06-30 | Q4 FY252025-03-31 |
|---|
| Revenue / Sales | ₹0.04 cr | ₹0.04 cr | ₹0.05 cr | ₹0.09 cr | ₹0.26 cr |
|---|
| Total expenses | ₹0.02 cr | ₹0.04 cr | ₹0.04 cr | ₹0.07 cr | ₹0.26 cr |
|---|
| Gross profit | ₹0.04 cr | ₹0.04 cr | ₹0.05 cr | ₹0.09 cr | ₹0.06 cr |
|---|
| Operating profit (EBIT) | ₹0.01 cr | ₹0 cr | ₹0.01 cr | ₹0.02 cr | ₹0 cr |
|---|
| Operating margin | 38.5% | 4.2% | 21.0% | 27.4% | 0.7% |
|---|
| Interest cost | — | ₹0 cr | ₹0 cr | ₹0 cr | ₹0 cr |
|---|
| Profit before tax | ₹0.01 cr | ₹0 cr | ₹0.01 cr | ₹0.02 cr | ₹0 cr |
|---|
| Tax expense | ₹0 cr | ₹0.01 cr | ₹0 cr | ₹0 cr | ₹0.09 cr |
|---|
| Effective tax rate | 0.0% | 623.2% | 0.0% | 0.0% | 4601.3% |
|---|
| Net profit (PAT) | ₹0.01 cr | -₹0.01 cr | ₹0.01 cr | ₹0.02 cr | -₹0.08 cr |
|---|
| Net profit margin | 38.5% | -21.8% | 21.0% | 27.4% | -31.7% |
|---|
| Basic EPS | ₹0.05 | ₹-0.03 | ₹0.03 | ₹0.08 | ₹-0.27 |
|---|
| Diluted EPS | ₹0.05 | ₹-0.03 | ₹0.03 | ₹0.08 | ₹-0.27 |
|---|
GVBL results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q1 FY26 | Q4 FY25 |
|---|
| Revenue YoY | -57.8% | -85.8% | — | — | — |
|---|
| Revenue QoQ | +1.3% | -25.0% | -44.4% | -65.8% | — |
|---|
| Operating profit YoY | -40.7% | -12.6% | — | — | — |
|---|
| Operating profit QoQ | +835.4% | -85.1% | -57.3% | +1279.3% | — |
|---|
| Net profit YoY | -40.7% | +90.2% | — | — | — |
|---|
| Net profit QoQ | +278.8% | -177.7% | -57.3% | +129.5% | — |
|---|
| EPS YoY | -37.5% | +90.1% | — | — | — |
|---|
| EPS QoQ | +286.6% | -189.3% | -62.5% | +129.6% | — |
|---|
GVBL annual results history
Full-year performance for GENOMIC VALLEY BIOTECH LIMITED, useful for reading each quarter in context.
GENOMIC VALLEY BIOTECH LIMITED annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹0.27 cr | ₹0.84 cr | ₹0.17 cr | ₹2.72 cr |
|---|
| Total expenses | ₹0.23 cr | ₹0.41 cr | ₹0.15 cr | ₹1.85 cr |
|---|
| Gross profit | ₹0.27 cr | ₹0.64 cr | ₹0.17 cr | ₹1.14 cr |
|---|
| Operating profit (EBIT) | ₹0.04 cr | ₹0.44 cr | ₹0.02 cr | ₹0.87 cr |
|---|
| Operating margin | 15.0% | 51.8% | 10.0% | 32.1% |
|---|
| Interest cost | ₹0 cr | ₹0 cr | ₹0 cr | ₹0 cr |
|---|
| Profit before tax | ₹0.04 cr | ₹0.44 cr | ₹0.02 cr | ₹0.65 cr |
|---|
| Tax expense | ₹0.01 cr | ₹0.09 cr | -₹0 cr | ₹0 cr |
|---|
| Effective tax rate | 24.3% | 19.3% | -0.2% | 0.1% |
|---|
| Net profit (PAT) | ₹0.03 cr | ₹0.36 cr | ₹0.02 cr | ₹0.65 cr |
|---|
| Net profit margin | 11.3% | 42.2% | 9.2% | 23.8% |
|---|
| Basic EPS | ₹0.10 | ₹1.17 | ₹0.05 | ₹2.12 |
|---|
| Diluted EPS | ₹0.10 | ₹1.17 | ₹0.05 | ₹2.12 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹0.04 cr against ₹0.09 cr in Q1 FY26, and ₹0.04 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +1.3%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹0.02 cr, or 61.5% of revenue, with operating profit declined -40.7% year on year.
Margins, tax and profitability
Net profit of ₹0.01 cr works out to a net margin of 38.5% compared with 27.4% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, GENOMIC VALLEY BIOTECH LIMITED reported profit before tax of ₹0.01 cr, a tax charge of ₹0 cr (effective rate 0.0%). Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from -₹0.01 cr in Q4 FY26 to ₹0.01 cr in Q1 FY27, a change of +278.8%.
Trailing twelve months and annual context
Across the trailing four quarters GENOMIC VALLEY BIOTECH LIMITED has generated revenue of ₹0.22 cr and net profit of ₹0.04 cr, a trailing net margin of 19.3%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹0.27 cr with net profit of ₹0.03 cr and EPS of ₹0.10, versus the prior year where revenue declined -68.3% and profit declined -91.5%.
What to watch in the next GVBL quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
GENOMIC VALLEY BIOTECH LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
GVBL results coverage
No results report published for GVBL yet — our desk covers each quarter within minutes of the filing.
GVBL quarterly results FAQs
What were GENOMIC VALLEY BIOTECH LIMITED (GVBL) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), GENOMIC VALLEY BIOTECH LIMITED reported revenue of ₹0.04 cr and net profit of ₹0.01 cr, a change of -40.7% year on year on -57.8% revenue growth. EPS stood at ₹0.05.
What is GVBL profit margin in Q1 FY27?
GENOMIC VALLEY BIOTECH LIMITED posted a net profit margin of 38.5% and an operating margin of 38.5% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹0.22 cr and net profit ₹0.04 cr.
Did GVBL results beat the previous quarter?
GENOMIC VALLEY BIOTECH LIMITED net profit changed +278.8% quarter on quarter, from -₹0.01 cr in Q4 FY26 to ₹0.01 cr in Q1 FY27.
When are GENOMIC VALLEY BIOTECH LIMITED (GVBL) quarterly results?
GENOMIC VALLEY BIOTECH LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see GVBL latest quarterly results?
Results coverage for GVBL will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the GVBL stock page.
What is GENOMIC VALLEY BIOTECH LIMITED annual revenue and profit?
For FY26, GENOMIC VALLEY BIOTECH LIMITED reported full-year revenue of ₹0.27 cr and net profit of ₹0.03 cr, with EPS of ₹0.10.
How many quarterly results has GVBL declared recently?
Past results dates for GVBL will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 11 Sept 2026. For information only, not investment advice.
